S9005 Mifepristone in Meningioma

PHASE3CompletedINTERVENTIONAL
Enrollment

193

Participants

Timeline

Start Date

August 31, 1992

Primary Completion Date

October 31, 2001

Study Completion Date

November 30, 2012

Conditions
Meningioma
Interventions
DRUG

Mifepristone

a 19 norsteroid with anti-progesterone and anti glucocorticoid activity which competitively inhibits binding of the hormone to its receptor

OTHER

Placebo

placebo matching mifepristone

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

SWOG Cancer Research Network

NETWORK